Can your diet shrink a fatty liver? new study tests three approaches

NCT ID NCT07304336

First seen Jan 05, 2026 · Last updated Jun 23, 2026 · Updated 24 times

Summary

This study tested three dietary strategies—low-carb, Mediterranean, and standard nutritional advice—in 173 overweight adults with MASLD (fatty liver disease) over 6 months. Researchers measured changes in liver fat and damage using scans and blood tests. The goal was to see which diet works best for managing this liver condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MASLD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • AOU Città della Salute e della Scienza di Torino, University of Torino, Torino.

    Torino, Torino, 10126, Italy

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

dietary intervention (low-carbohydrate diet, Mediterranean diet, or standard nutritional recommendations)

What this could lead to

If successful, this could show that specific diets effectively reduce liver fat and damage in people with MASLD, offering practical dietary guidance.

What could go wrong

This is a completed trial with 173 participants, so results are limited in size and may not apply to everyone. Dietary adherence can vary, and the study is not blinded, which may introduce bias.

Conditions

The condition(s) this trial relates to.

Digestive System Diseases metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.